Peter Feinstein
InvestorVenture Partner at Bioventures Investors
Massachusetts
Writes $5M – $25M checks · typically $10M
Find your path to Peter
16 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.
Marc GoldbergunlockedPeter: together at Bioventures Investors
×11Peter: together at Bioventures Investors
About
Co-founder of BioVentures Investors (with Marc Goldberg), forming its first fund in 1998, and currently a Venture Partner. He previously founded and led Feinstein Kean Healthcare, held a corporate communications VP role at Biogen, and co-founded the Massachusetts Biotechnology Council.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- BioVentures InvestorsVenture Partner
Colleagues at Bioventures Investors
Charles Bridges
Advisory Board at Bioventures Investors
Chris Thompson
Keystone Partner at Bioventures Investors
Donna Edmonds
Advisory Board at Bioventures Investors
James Lousararian
Managing Director at Bioventures Investors
Jeffrey Barnes
Managing Director at Bioventures Investors
John Osborn
Venture Partner and Principal at Bioventures Investors
Jonathan Cohen
Keystone Partner at Bioventures Investors
Jonathan Gertler
Managing Director at Bioventures Investors
Frequently asked questions
- Who is Peter Feinstein?
- Co-founder of BioVentures Investors (with Marc Goldberg), forming its first fund in 1998, and currently a Venture Partner. He previously founded and led Feinstein Kean Healthcare, held a corporate communications VP role at Biogen, and co-founded the Massachusetts Biotechnology Council.
- Where does Peter Feinstein work?
- Peter Feinstein is Venture Partner at Bioventures Investors.
- What does Peter Feinstein invest in?
- Peter Feinstein invests in Biotech.
- What check size does Peter Feinstein write?
- Peter Feinstein typically writes checks of $5M – $25M.
Shared employers
Also worked at BioVentures Investors6
Jeffrey BarnesManaging Director at Bioventures InvestorsJonathan GertlerManaging Director at Bioventures InvestorsTony LyonsManaging Director at Bioventures InvestorsRuss RapaportAssociate at 1315 CapitalVladimir WalkoBusiness Development Officer at Signet Healthcare PartnersJohn OsbornVenture Partner and Principal at Bioventures Investors












